证券代码：300505 证券简称：川金诺 公告编号：2025-003 特此公告。 昆明川金诺化工股份有限公司 董 事 会 申请授信的有效期自公司 2024 年第一次临时股东大会审议通过之日起 1 年。授信额度、授信期限最终以银行实际审批为准，授信额度可循环使用； 公司对子公司担保金额以实际发生额为准。如担保方式与上述情形存在变化 的，公司将按相关规定另行审议。具体内容详见公司于 2024 年 3 月 5 日在中 国证监会指定的创业板信息披露平台巨潮资讯网（http://www.cninfo.com.c n）上发布的《关于公司及子公司 2024 年度向银行申请综合授信额度暨公司 为子公司申请综合授信额度提供担保的公告》（公告编号：2024-007）。 近日，公司与中信银行股份有限公司昆明分行（以下简称"中信银行"） 签署了《综合授信合同》，由公司向中信银行申请授信 7,000 万元（大写： 柒仟万元整），该笔授信为信用授信，无须提供担保，综合授信额度使用期 限自 2025 年 2 月 10 日起至 2025 年 12 月 10 日止。 一、备查文件 1、《综合授信合同》； 昆明川金诺化工股份有限公司 关于公司向 ...

关于公司董事、总经理减持股份预披露的公告 公司董事、总经理魏家贵保证向公司提供的信息真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 证券代码：300505 证券简称：川金诺 公告编号：2025-002 昆明川金诺化工股份有限公司 特别提示： 1、持有本公司股份4,246,091股（占本公司总股本比例1.5448%）的董事、总经 理魏家贵先生计划自本公告披露之日起15个交易日后的3个月内以集中竞价或大宗交 易方式减持本公司股份不超过1,000,000股（占本公司总股本比例0.3638%）。 2、魏家贵先生近三年未减持公司股份，本次减持是个人资金需要。 昆明川金诺化工股份有限公司（以下简称"公司"或"川金诺"）近日收到公 司董事、总经理魏家贵先生提交的《股份减持计划告知函》，现将有关情况公告如 下： 一、股东的基本情况 | 股东 | 股东身份 | 截至本公告日 | 持有股份占公司总股本的 | | --- | --- | --- | --- | | 名称 | | 持有公司股份数量（股） | 比例 | | 魏家贵 | 董事、总经理 | 4, ...

Group 1: Company Overview - The company operates two production bases located in Kunming and Fangchenggang, with main products including feed-grade phosphates, phosphoric acid, and fertilizers. The designed production capacities are: DCP 100,000 tons/year, MCP 150,000 tons/year, and others totaling 150,000 tons/year for the Kunming base, and 140,000 tons/year for calcium carbonate and 100,000 tons/year for phosphoric acid at the Fangchenggang base [2][3]. Group 2: Financial Performance - The company announced a turnaround in 2024, attributing the profit recovery to a recovery in the phosphate chemical market compared to 2023 and effective adjustment of product structure based on market conditions [3]. Group 3: Raw Material Sourcing - Phosphate rock is primarily sourced locally for the Kunming base, utilizing low-grade phosphate rock to produce high-quality phosphate concentrate, which offers a price advantage over high-grade rock. The Fangchenggang base sources phosphate rock from overseas and northern China, leveraging port advantages for cost-effective procurement [3]. Group 4: Environmental Management - The company utilizes most of the phosphogypsum produced at the Kunming base in cement production and ecological restoration, while the remaining is treated according to environmental standards. The Fangchenggang base processes phosphogypsum into cement retarders for sale [3][4]. Group 5: Strategic Direction - The company is focused on three strategic directions: developing fine phosphates, exploring opportunities in the renewable energy sector, and considering overseas investments [4].

Revenue Forecast - The company expects revenue for 2024 to be between 300,000 and 340,000 million yuan, representing an increase of 10.65% to 25.40% compared to the previous year's revenue of 271,134.01 million yuan[3]. Profit Projections - The net profit attributable to shareholders is projected to be between 15,000 and 18,500 million yuan, a significant increase of 264.01% to 302.28% from a loss of 9,145.95 million yuan in the previous year[3]. - The net profit after deducting non-recurring gains and losses is expected to be between 14,140 and 17,640 million yuan, reflecting an increase of 235.39% to 268.90% from a loss of 10,443.75 million yuan last year[3]. - Non-recurring gains and losses are estimated to impact net profit by approximately 820 to 900 million yuan during the reporting period[5]. Strategic Plans - The company plans to adjust its product structure and optimize production organization, leading to an improvement in overall gross profit margin[5]. - The company aims to leverage the recovery in the phosphate chemical market to improve its performance in 2024[4]. Audit and Reporting - The company has communicated with its auditing firm regarding the performance forecast, and there are no discrepancies noted[4]. - The performance forecast is based on preliminary calculations by the company's finance department and has not yet been audited[6]. - The reporting period for the performance forecast is from January 1, 2024, to December 31, 2024[4]. Investment Caution - Investors are advised to exercise caution and consider investment risks due to the uncertainties in the final amounts of impairment provisions[5].

证券代码：300505 证券简称：川金诺 公告编号：2024-060 昆明川金诺化工股份有限公司 关于变更公司办公地址的公告 公司网址：http://www.cjnphos.com 电子信箱：cjnzqb@163.com 投资者联系电话：0871-67436102 传真：0871-67412848 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 昆明川金诺化工股份有限公司（以下简称"公司"或"川金诺"）因经营发 展需要，于近日搬迁至新办公地址，具体变更情况如下： | | 云南省昆明市呈贡区上 | | | 云南省昆明市呈贡区乌龙街道办事处七 | | --- | --- | --- | --- | --- | | | 座 10 | A | 楼 | 彩云南第壹城 1#办公楼（双子星·天 | | 变更事项 办公地址 | 变更前 海东盟大厦 | | | 变更后 枢）55 层 | 公司董事会秘书和证券事务代表联系地址、信息披露及备置地点同时变更。 除上述变更外，公司注册地址、公司网址、电子信箱等其他联系方式均保持不变。 具体为： 注册地址：云南省昆明市东川区铜都镇四方地工 ...

证券代码：300505 证券简称：川金诺 公告编号：2024-059 昆明川金诺化工股份有限公司（以下简称"公司"或"川金诺"）于2024 年6月20日召开第五届董事会第七次会议及第五届监事会第六次会议，审议通过 了《关于使用部分暂时闲置募集资金进行现金管理的议案》，同意公司及公司募 投项目实施主体合计使用额度不超过40,000万元人民币的暂时闲置募集资金进 行现金管理，该额度在董事会审议通过之日起12个月的有效期内循环滚动使用， 具体详见公司于2024年6月21日披露于巨潮资讯网的《关于使用部分暂时闲置募 集资金进行现金管理的公告》（公告编号：2024-029）。 目前在授权范围内使用闲置募集资金购买的部分理财产品已到期赎回，现就 有关进展情况公告如下： | 买入方 | 资金 | 产品 发行 | 产品名称 | 产品类型 | 认购金 额（万 | 产品起 | 产品到期 | 是否 到期 | 实现收益 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 来源 | | | | | 息日 | 日 | | （万元） | | | | 机构 ...

证券代码：300505 证券简称：川金诺 公告编号：2024-058 昆明川金诺化工股份有限公司 关于公司为子公司申请综合授信额度提供担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、担保情况概述 昆明川金诺化工股份有限公司（以下简称"公司"或"川金诺"）于 2024 年 3 月 4 日召开第五届董事会第四次会议、第五届监事会第三次会议，于 2024 年 3 月 21 日召开 2024 年第一次临时股东大会，审议通过了《关于公司及子公司 2024 年度向银行申请综合授信额度暨公司为子公司申请综合授信额度提供担保 的议案》，由公司为控股子公司广西川金诺化工有限公司（以下简称"广西川金 诺化工"）向银行申请授信提供担保，担保金额合计不超过 70,000 万元。担保 方式包括但不限于一般保证、连带责任保证、抵押、质押等。 申请授信的有效期自公司 2024 年第一次临时股东大会审议通过之日起 1 年。 授信额度、授信期限最终以银行实际审批为准，授信额度可循环使用；具体担保金 额、担保期限以及签约时间以实际签署的合同为准，最终实际担保金额不超过审 议的 ...

证券代码：300505 证券简称：川金诺 公告编号：2024-057 昆明川金诺化工股份有限公司 关于全资子公司在香港完成注册登记的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 昆明川金诺化工股份有限公司（下称"公司"）于 2024 年 9 月 2 日召开第 五届董事会第十次会议，审议通过了《关于对外投资设立境外子公司的议案》， 具体内容详见公司于 2024 年 9 月 3 日在巨潮资讯网（http://www.cninfo.com.cn） 发布的《第五届董事会第十次会议决议之公告》（公告编号：2024-048）、《关 于对外投资设立境外子公司的公告》（公告编号：2024-049）。 近日，公司已办理完成注册登记手续，并取得了香港特别行政区公司注册处 签发的《公司注册证明书》和《商业登记证》，现将有关情况公告如下： 二、备查文件 1、《公司注册证明书》； 2、《商业登记证》。 特此公告。 昆明川金诺化工股份有限公司 董 事 会 2024 年 12 月 3 日 2、英文名称：Chuan Jin Nuo Hong Kong Co., Limited 3、注 ...

Revenue and Profit - Revenue for Q3 2024 reached ¥836,666,013.90, an increase of 6.95% year-over-year, while year-to-date revenue totaled ¥2,200,104,823.51, up 14.90% compared to the same period last year[1] - Net profit attributable to shareholders for Q3 2024 was ¥43,852,073.46, a significant increase of 160.50% year-over-year, with year-to-date net profit reaching ¥110,452,127.31, up 202.18%[1] - Basic earnings per share for Q3 2024 was ¥0.1595, reflecting a 153.20% increase compared to the same period last year, while year-to-date earnings per share was ¥0.4018, up 187.67%[1] - Total operating revenue for the period reached ¥2,200,104,823.51, an increase of 14.93% compared to ¥1,914,780,105.91 in the previous period[14] - Net profit for the period was ¥115,434,143.39, a significant recovery from a net loss of ¥114,935,234.23 in the previous period[15] - Operating profit improved to ¥132,866,660.84, compared to an operating loss of ¥148,904,579.01 in the previous period[15] - Total comprehensive income for the period was ¥116,250,288.55, compared to a loss of ¥114,935,234.23 in the previous period[15] - The basic and diluted earnings per share improved to ¥0.4018 from a loss of ¥0.4583 in the previous period[15] Assets and Liabilities - Total assets as of the end of Q3 2024 amounted to ¥3,609,053,073.56, representing a 1.55% increase from the end of the previous year[1] - The company's equity attributable to shareholders increased to ¥2,480,121,749.00, a rise of 3.39% compared to the end of the previous year[1] - Current liabilities increased to CNY 937,568,288.32 from CNY 891,638,748.74, an increase of approximately 5.2%[12] - Non-current liabilities decreased to CNY 141,730,821.89 from CNY 218,832,780.65, a decrease of about 35.3%[12] - The total equity remained stable at CNY 1,282,067,110.26[12] Cash Flow - Cash flow from operating activities for the year-to-date period was ¥111,084,484.60, an increase of 66.04% compared to the same period last year[1] - Cash flow from operating activities generated a net inflow of ¥111,084,484.60, up from ¥66,900,405.51 in the previous period[16] - The cash inflow from financing activities totaled 478,000,000.00 CNY, down from 1,495,041,244.50 CNY in the prior period[17] - The net cash flow from financing activities was -135,825,266.79 CNY, a significant decrease compared to 909,213,755.05 CNY in the same period last year[17] - The company reported a net decrease in cash and cash equivalents of -142,124,672.20 CNY for the quarter, contrasting with an increase of 695,384,834.25 CNY in the previous year[17] Investments and Expenses - Cash flow from investment activities included a cash recovery of RMB 66,000,000.00 from financial management of raised funds, marking a 100% increase[6] - Cash paid for investments decreased by 92.12% to RMB 7,723,787.63, as the previous year included payments for acquiring equity in Yingkou Chuanxin Chemical[6] - Research and development expenses decreased to ¥35,710,720.94 from ¥44,296,479.58, reflecting a 19.5% reduction[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 35,040, with the largest shareholder holding 26.33%[7] - The largest shareholder, Liu Ma, held 72,364,501 shares, with 54,273,376 shares under lock-up conditions[7] Government Support - Non-operating income from government subsidies for Q3 2024 was ¥4,731,558.12, with year-to-date total at ¥11,775,705.59, indicating a strong reliance on government support[2] Other Financial Metrics - The company experienced a 518.32% increase in contract liabilities, attributed to an increase in advance payments received under contracts[4] - Financial expenses decreased by 81.71% due to a reduction in bank loan scale and increased interest income from deposits[5] - The cash and cash equivalents at the end of Q3 2024 amounted to 582,566,236.55 CNY, down from 974,256,924.35 CNY at the end of the previous period[17] - The impact of exchange rate changes on cash and cash equivalents was 6,147,666.25 CNY, compared to 514,506.14 CNY in the previous period[17] Future Plans - The company plans to enhance its market expansion strategies and invest in new product development[10]

Revenue Projections - For the first three quarters of 2024, the company expects revenue between 210,000 and 230,000 million CNY, representing an increase of 9.67% to 20.12% compared to the same period last year[2]. - For Q3 2024, the company anticipates revenue between 80,000 and 86,000 million CNY, reflecting a year-over-year increase of 2.27% to 9.94% from 78,227 million CNY[3]. Profit Projections - The net profit attributable to shareholders is projected to be between 10,100 and 12,100 million CNY, an increase of 193.44% to 211.94% year-over-year, compared to a loss of 10,809 million CNY in the previous year[2]. - The net profit attributable to shareholders for Q3 2024 is expected to be between 3,500 and 5,500 million CNY, marking an increase of 148.28% to 175.87% compared to a loss of 7,249 million CNY in the same quarter last year[3]. - The net profit after deducting non-recurring gains and losses for Q3 2024 is projected to be between 3,260 and 5,260 million CNY, up 143.95% to 170.92% from a loss of 7,417 million CNY in the previous year[4]. Factors Influencing Performance - The company attributes the improved performance to the recovery of the phosphate chemical market and strategic adjustments in product structure and production organization[6]. - Non-recurring gains and losses are expected to impact the net profit by approximately 9.2 million CNY during the reporting period[6]. Financial Reporting and Caution - The financial data in this earnings forecast has not been audited by a registered accountant[5]. - The company will provide detailed financial data in the Q3 2024 report, urging investors to make cautious decisions and be aware of investment risks[7].